论文部分内容阅读
目的观察儿童病毒性腹泻行布拉氏酵母菌联合双歧杆菌三联活菌治疗的疗效。方法资料选取我院2013年6月~2014年6月收治的病毒性腹泻患儿128例,根据不同的治疗方案分为两组,对照组64例行双歧杆菌三联活菌治疗,实验组64例行布拉氏酵母菌联合双歧杆菌三联活菌治疗,比较两组疗效、腹泻时间及不良反应情况。结果实验组治疗总有效率93.75%比对照组73.44%高,且腹泻持续时间短于对照组,两者比较差异有统计学意义(P<0.05);两组患者不良反应发生率比较差异无统计学意义(P>0.05)。结论布拉氏酵母菌联合双歧杆菌三联活菌治疗病毒性腹泻患儿疗效显著,可有效缩短腹泻持续时间,且安全性较高,值得临床推广应用。
Objective To observe the curative effect of Brachyerella spp. Combined with Bifidobacterium triple viable bacteria in children with viral diarrhea. Methods Data 128 cases of viral diarrhea admitted to our hospital from June 2013 to June 2014 were divided into two groups according to different treatment plans, 64 cases of control group were treated with Bifidobacterium triple viable bacteria, experimental group 64 Routine Bourgeon combined with Bifidobacterium triple viable bacteria treatment, the two groups were compared efficacy, diarrhea time and adverse reactions. Results The total effective rate of the experimental group was 93.75% higher than that of the control group 73.44%, and the duration of diarrhea was shorter than that of the control group (P <0.05). There was no statistical difference in the incidence of adverse reactions between the two groups Significance (P> 0.05). Conclusion The combination of Bragilis yeast and Bifidobacterium triple viable bacteria in the treatment of children with viral diarrhea has significant curative effect, which can effectively shorten the duration of diarrhea and is safe. It is worthy of clinical application.